The Potent Protein Kinase C-Selective Inhibitor AEB071 (Sotrastaurin) Represents a New Class of Immunosuppressive Agents Affecting Early T-Cell ActivationJean-Pierre Evenou, Gottfried Baier, Sylvain Cottens et al.|Journal of Pharmacology and Experimental Therapeutics|2009Cited by 160
Discovery of 3-(1<i>H</i>-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a Potent and Selective Inhibitor of Protein Kinase C IsotypesJürgen Wagner, Sylvain Cottens, Peter Matt et al.|Journal of Medicinal Chemistry|2009Cited by 135
Structure–Activity Relationship and Pharmacokinetic Studies of Sotrastaurin (AEB071), a Promising Novel Medicine for Prevention of Graft Rejection and Treatment of PsoriasisJürgen Wagner, Sylvain Cottens, Peter Matt et al.|Journal of Medicinal Chemistry|2011Cited by 39
Rational Design, Synthesis, and X-ray Structure of Selective Noncovalent Thrombin InhibitorsJürgen Wagner, Dieter Wagner, Jörg Kallen et al.|Journal of Medicinal Chemistry|1998Cited by 35
Discovery of 3-(1<em>H</em>-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4- yl]-pyrrole-2,5-dione (AEB071), a potent and selective inhibitor of protein kinase C isotypesJürgen Wagner, Sylvain Cottens, Peter Matt et al.|DORA PSI (Paul Scherrer Institute)|2009Cited by 0